P31 Impact of COVID-19 on HTA/PRMA of Medicinal Products in Europe: A Payer Perspective
Jan 1, 2022, 00:00 AM
10.1016/j.jval.2021.11.030
https://www.valueinhealthjournal.com/article/S1098-3015(21)01825-8/fulltext
Section Title :
Section Order :
11097
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(21)01825-8&doi=10.1016/j.jval.2021.11.030